← Cellebrite DI Ltd.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net Income (Loss) | ($1.9m) |
$5.8m
+408.16%
|
$71.4m
+1135.01%
|
$120.8m
+69.20%
|
($81.1m)
-167.13%
|
($283.0m)
-248.96%
|
$78.3m
+127.68%
|
— | |
| Amortization of premium, discount and accrued interest on marketable securities | — | $0 | $0 | ($372k) | ($1.1m) | ($2.9m) | ($2.4m) | — | |
| Depreciation and amortization | $4.1m | $5.9m | $7.0m | $9.2m | $10.0m | $10.6m | $11.9m | $16.2m | |
| Deferred tax assets, net | ($1.7m) | ($2.8m) | ($1.6m) | ($2.4m) | $5.1m | ($4.0m) | $75k | — | |
| Share-based compensation | $12.8m | $7.3m | $6.5m | $13.7m | $19.0m | $30.6m | $44.9m | $50.5m | |
| (Increase) decrease in trade receivables | ($12.2m) | ($19.7m) | ($2.0m) | ($12.9m) | $2.3m | ($5.8m) | ($15.8m) | — | |
| Decrease in inventories | $794k | ($693k) | ($1.8m) | ($3.7m) | $243k | $982k | $1.6m | — | |
| Increase in trade payables | $974k | ($1.4m) | $4.2m | ($5.5m) | $3.7m | $2.8m | $4.9m | — | |
| Increase in other accounts payable and accrued expenses | ($158k) | $22.4m | $5.1m | ($8.9m) | $734k | $17.6m | $4.2m | — | |
| Increase in deferred revenues | $15.8m | $47.7m | $21.8m | $39.0m | $46.1m | $22.3m | $49.8m | — | |
| Decrease (increase) in prepaid expenses and other current assets | ($3.1m) | $335k | ($8.3m) | ($5.7m) | ($9.2m) | $3.2m | $5.6m | — | |
| Net Cash Provided by (Used in) Operating Activities, Total | $16.1m |
$66.5m
+312.26%
|
$36.1m
-45.79%
|
$20.6m
-42.92%
|
$102.1m
+395.98%
|
$132.2m
+29.51%
|
$173.5m
+31.30%
|
$172.6m
-0.57%
|
|
| Disposal and write-off of property and equipment | — | — | — | — | $0 | $0 | $554k | — | |
| Payments to Acquire Property, Plant, and Equipment | ($6.2m) | ($6.2m) | ($5.1m) | ($6.9m) | ($5.2m) | ($8.6m) | ($13.2m) | ($21.0m) | |
| Interest on deposits and investments | — | $0 | $0 | ($684k) | ($7.7m) | ($10.7m) | ($8.2m) | — | |
| Payments to Acquire Marketable Securities | — | $0 | $0 | ($89.4m) | ($55.3m) | ($127.8m) | ($321.2m) | — | |
| Proceeds from maturity of marketable securities | — | $0 | $0 | $22.3m | $56.3m | $60.0m | $153.0m | — | |
| Proceeds from sales of marketable securities | — | — | — | — | $0 | $0 | $59.8m | — | |
| Payments to Acquire Short-Term Investments | — | ($138.5m) | ($21.0m) | ($76.0m) | ($89.0m) | ($207.0m) | ($187.0m) | — | |
| Proceeds from Sale of Short-Term Investments | — | $153.3m | $94.3m | $60.9m | $73.4m | $138.7m | $187.9m | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | ($15.0m) | ($20.0m) | $0 | $0 | ($2.7m) | ($147.5m) | ($162.7m) | |
| Net Cash Provided by (Used in) Investing Activities, Total | ($46.7m) | ($6.4m) | $45.2m | ($91.2m) | ($22.5m) | ($149.5m) | ($268.2m) | ($155.3m) | |
| Net cash provided by financing activities | $75.5m |
($8.6m)
-111.38%
|
($68.4m)
-695.96%
|
$14.0m
+120.42%
|
$21.8m
+55.80%
|
$20.7m
-5.12%
|
$25.1m
+21.32%
|
$24.9m
-0.44%
|
|
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect, Total | $44.9m | $51.5m | $12.9m | ($56.7m) | $101.3m | $3.3m | ($69.7m) | $132.6m | |
| Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Beginning Balance | $81.7m | $133.8m | $146.0m | $87.6m | $189.5m | $191.7m | $124.5m | $132.6m | |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | ($67k) | $695k | ($754k) | ($1.6m) | $589k | ($1.2m) | $2.5m | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Abandonment of right‑of‑use assets and disposal of leasehold improvements | — | — | — | — | $0 | $0 | $1.8m | — | |
| Remeasurement of Warrant liability | $0 | $0 | ($12.0m) | ($36.5m) | $34.1m | $110.7m | $0 | — | |
| Remeasurement of Restricted Sponsor Shares liability | — | $0 | ($17.6m) | ($27.2m) | $29.7m | $65.9m | $0 | — | |
| Remeasurement of Price Adjustment Shares liability | — | $0 | ($38.3m) | ($53.2m) | $55.5m | $173.1m | $0 | — | |
| Increase in other non-current assets | ($27k) | ($339k) | ($1.4m) | $227k | ($5.6m) | ($341k) | ($6.9m) | — | |
| Changes in operating lease right-of-use assets | — | $0 | $0 | $4.7m | $4.4m | $5.3m | $4.6m | — | |
| Changes in operating lease liabilities | — | $0 | $0 | ($6.0m) | ($4.2m) | ($4.8m) | $547k | — | |
| (Decrease) increase in other long-term liabilities | $644k | $1.4m | $3.0m | ($4.1m) | $121k | $880k | ($2.0m) | — | |
| Payments to Acquire Intangible Assets | $0 | $0 | $3.0m | ($2.2m) | ($2.7m) | ($2.0m) | $0 | ($7.1m) | |
| Exercise of options | $141k | $1.5m | $2.3m | $12.6m | $19.1m | $17.3m | $20.1m | — | |
| Proceeds from Employee Share Purchase Plan | — | $0 | $0 | $1.3m | $2.6m | $3.3m | $5.0m | — | |
| Exercise of public warrants | — | $0 | $0 | $5k | $0 | $53k | $0 | — | |
| Redemption of public warrants | — | — | — | $0 | $0 | ($11k) | $0 | — | |
| Income Taxes Paid, Net | $3.0m | $2.9m | $8.2m | $9.1m | $10.0m | $7.7m | ($549k) | — | |
| Operating lease liabilities arising from obtaining right of use assets | — | — | $0 | $0 | $4.4m | $1.9m | $11.2m | — | |
| Reclass and release of Restricted Sponsor Share | — | — | — | $0 | $0 | $113.1m | $0 | — | |
| Reclassification and issuance of Price Adjustment Share | — | — | — | $0 | $0 | $164.8m | $0 | — |